MedPath

Effect of oral magnesium supplementation on cardio metabolic markers in people at risk of diabetes

Phase 3
Conditions
Prediabetes.
Malnutrition-related diabetes mellitus
Registration Number
IRCT20181226042129N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
84
Inclusion Criteria

prediabetes condition
not consuming magnesium supplements in last 6 months and serum magnesium level less than 2mg/dL
GFR > 60mL/min
Blood pressure less than 140 / 90 mmHg

Exclusion Criteria

Pregnancy
Chronic diseases
Liver diseases
Chronic diarrhea
Smoking
Consume diuretics
Consuming anti hypertensive drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting Blood Sugar. Timepoint: Day 0 and day 120. Method of measurement: Lab test.;HbA1c. Timepoint: Day 0 and 120. Method of measurement: Lab test.;Lipid profile. Timepoint: Day 0 and 120. Method of measurement: Lab test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath